Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China

IMPORTANCE: Dyslipidemia, the prevalence of which historically has been low in China, is emerging as the second leading yet often unaddressed factor associated with the risk of cardiovascular diseases. However, recent national data on the prevalence, treatment, and control of dyslipidemia are lackin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yuan, Zhang, Haibo, Lu, Jiapeng, Ding, Qinglan, Li, Xinyue, Wang, Xiaochen, Sun, Daqi, Tan, Lingyi, Mu, Lin, Liu, Jiamin, Feng, Fang, Yang, Hao, Zhao, Hongyu, Schulz, Wade L., Krumholz, Harlan M., Pan, Xiangbin, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482054/
https://www.ncbi.nlm.nih.gov/pubmed/34586366
http://dx.doi.org/10.1001/jamanetworkopen.2021.27573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482054/
https://www.ncbi.nlm.nih.gov/pubmed/34586366
http://dx.doi.org/10.1001/jamanetworkopen.2021.27573

Ejemplares similares